Эндокринология, диабет и метаболизм
1133 статей · 42 журналов
Журналы подкатегории (42)
- AACE Endocrinology and Diabetes · Elsevier (87)
- Diabetes, Obesity and Metabolism · Wiley (81)
- Endocrine Practice · Elsevier (79)
- Bone · Elsevier (70)
- Pancreatology · Elsevier (70)
- Diabetes Epidemiology and Management · Elsevier (68)
- Nutrition · Elsevier (66)
- Endocrinology & Metabolism Clinics of North America · Elsevier (54)
- The Journal of Nutritional Biochemistry · Elsevier (52)
- Endocrinología, Diabetes y Nutrición · Elsevier (50)
- Bone Reports · Elsevier (48)
- Nutrition Research · Elsevier (46)
- Metabolism · Elsevier (44)
- Endocrine and Metabolic Science · Elsevier (40)
- Endocrinology, Diabetes and Metabolism · Wiley (40)
- Obesity Research & Clinical Practice · Elsevier (38)
- Journal of Clinical Densitometry · Elsevier (35)
- Cytokine & Growth Factor Reviews · Elsevier (34)
- Growth Hormone & IGF Research · Elsevier (34)
- Best Practice & Research Clinical Endocrinology & Metabolism · Elsevier (30)
- Nature Reviews Endocrinology · Springer Nature (11)
- Journal of Clinical Hypertension · Wiley (9)
- Journal of Clinical and Translational Endocrinology · Elsevier (9)
- Journal of Diabetes · Wiley (9)
- International Journal of Obesity · Springer Nature (8)
- International Journal of Obesity Supplements · Springer Nature (8)
- npj Metabolic Health and Disease · Springer Nature (8)
- Clinical Obesity · Wiley (5)
- Acta Diabetologica · Springer Nature (0)
- BMC Endocrine Disorders · Springer Nature (0)
- BMC Nutrition · Springer Nature (0)
- Cardiovascular Diabetology · Springer Nature (0)
- Cardiovascular Diabetology – Endocrinology Reports · Springer Nature (0)
- Current Osteoporosis Reports · Springer Nature (0)
- Endocrine · Springer Nature (0)
- Hormones · Springer Nature (0)
- Journal of Bone and Mineral Metabolism · Springer Nature (0)
- Journal of Diabetes & Metabolic Disorders · Springer Nature (0)
- Journal of Endocrinological Investigation · Springer Nature (0)
- Osteoporosis International · Springer Nature (0)
- Pituitary · Springer Nature (0)
- Reviews in Endocrine and Metabolic Disorders · Springer Nature (0)
-
Global Trends and Exposure Profiling of Early‐Onset Type 2 Diabetes: An Ecological Analysis Using Machine Learning
ABSTRACT Background Early‐onset Type 2 diabetes (EOT2D) is an increasing global health concern. We examined global trends in EOT2D incidence and identified robust population‐level exposure correlates. Methods Using the data from the GBD...
-
Two‐Year Trajectories of DIAL2‐Predicted Cardiovascular Risk After Initiation of Semaglutide, Empagliflozin or Their Combination: The DIAL‐STEP Study
ABSTRACT Aims To describe observed clinical changes and trajectories of DIAL2‐predicted cardiovascular risk during 24 months of oral semaglutide, empagliflozin or combination treatment. Materials and Methods This retrospective cohort...
-
Genetically Predicted β‐Hydroxybutyrate and Coronary Atherosclerosis: Mendelian Randomization and APOE‐Associated Transcriptomic Signatures in Human Atherosclerotic Plaques
ABSTRACT Aims Ketone bodies are implicated in cardiovascular metabolism, yet the contributions of β‐hydroxybutyrate (BHB), acetoacetate and acetone to coronary atherosclerosis remain unclear. Methods We integrated Mendelian...
-
Continuous Glucose Monitoring in Obesity Without Diabetes: An Unnecessary Gadget or a Gateway to Precision Care?
Diabetes, Obesity and Metabolism, EarlyView.
-
Diabetic Ketoacidosis: Systematic Review and Meta‐Analysis
ABSTRACT Aims Diabetic ketoacidosis (DKA) remains a major cause of diabetes‐related morbidity and mortality worldwide, yet evidence on its management and clinical outcomes across healthcare settings remains limited. We conducted a...
-
Diabetes Type and Perinatal Adverse Outcomes Among Women in Pregnancy and Neonates in Japan: A Cohort Study Using a Large‐Scale Database
ABSTRACT Aims To compare maternal and neonatal outcomes across gestational diabetes, preexisting diabetes, overt diabetes in pregnancy and normoglycaemia in Japan. Materials and Methods Using the JMDC claims database, we conducted a...
-
Longitudinal Associations of Changes in Body Mass Index and Waist‐to‐Height Ratio With Cardiometabolic Risk Factors: Sex‐Specific Analyses in UK Biobank
ABSTRACT Aims To examine associations of within‐person changes in body mass index (BMI) and waist‐to‐height ratio (WHtR) with cardiometabolic outcomes, characterise dose–response non‐linearity and investigate effect modification by sex....
-
Development and Validation of 10‐Year Prediction Models for Cardiovascular, Kidney and Metabolic Events Among Chinese Patients With Prediabetes in Hong Kong
ABSTRACT Aims Risk stratification can support frontline doctors and patients by enabling care and empowering early prevention of cardiovascular, kidney and metabolic disease. We aimed to develop and validate 10‐year prediction models...
-
Birthweight and Glucose Tolerance Status Are Associated With Organ Sizes in Older Adults
ABSTRACT Aims Low birthweight is a risk factor of Type 2 diabetes and cardiovascular disease. Organ size is related to organ function and disease, but few studies have examined cardiometabolic organ sizes in relation to birthweight and...
-
Persistent Gaps in Semaglutide and Tirzepatide Prescribing Among Adults With Class III Obesity Without Type 2 Diabetes
Diabetes, Obesity and Metabolism, EarlyView.
-
Effectiveness of GLP‐1 RAs and SGLT‐2is for Weight Loss and Glycaemic Control: An Observational Emulation of a Target Trial
ABSTRACT Aims Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2is) are both recommended as second‐line treatments for individuals with Type 2 diabetes and obesity, but long‐term...
-
GLP‐1 Receptor Agonists Use in Patients With Prior Psychotropic Treatment: A Nationwide Cohort Study
ABSTRACT Aims Psychotropic medications are frequently associated with weight gain and metabolic syndrome. While GLP‐1 receptor agonists (GLP‐1RAs) have generated interest for managing these adverse effects, their current uses in...
-
CD81 defines a new paradigm for beige adipocyte progenitor biology
Nature Reviews Endocrinology, Published online: 10 November 2026; doi:10.1038/s41574-026-01332-y CD81 defines a new paradigm for beige adipocyte progenitor biology
-
Clinical Characteristics, Effectiveness and Safety Outcomes in Chinese Patients With Chronic Kidney Disease and Type 2 Diabetes Who Initiated Finerenone: A Retrospective Real‐World Cohort Study From the FOUNTAIN Platform
ABSTRACT Aims Finerenone was approved in China in 2022 for adult patients with chronic kidney disease (CKD) associated with Type 2 diabetes (T2D). This study aimed to characterize Chinese patients with CKD and T2D who initiated...
-
Effects of GLP‐1 Receptor Agonists on Hyperuricemia, Serum Uric Acid and Gout: A Systematic Review and Meta‐Analysis
ABSTRACT Objectives Hyperuricemia and gout are common but underappreciated comorbidities in Type 2 diabetes (T2D), obesity and chronic kidney disease (CKD). We aimed to quantify the pooled effects of glucagon‐like peptide‐1 receptor...
-
Weaker or Just Lighter? Monitoring Strength and Function, Not Just Lean Mass, During GLP‐1 Weight Loss
ABSTRACT Aims Body‐composition studies of GLP‐1‐based therapy report how much of the weight lost is lean mass, not whether the patient is getting weaker. This review asks how to monitor strength and function during treatment. Materials...
-
Lean Body Mass During GLP‐1‐Based Therapy and the Potential Role of Dietary Protein: Evidence From Energy‐Restriction Trials
Diabetes, Obesity and Metabolism, EarlyView.
-
Longitudinal Taxonomic and Predicted Functional Gut Microbiome Responses to Tirzepatide and Semaglutide: An Exploratory Secondary Analysis of the OMDOT‐1 Randomized Controlled Trial
ABSTRACT Aims Glucagon‐like peptide‐1‐based therapies improve metabolic outcomes, but longitudinal gut microbiome dynamics remain poorly characterized. We compared taxonomic and predicted functional microbiome responses to tirzepatide...
-
The Growing Incretin Mimetic Therapy Revolution and Potential Ophthalmic Risks: Need for Clinicians to Focus on Ophthalmic Surveillance
Diabetes, Obesity and Metabolism, EarlyView.
-
Guideline Implementation Gap in Preeclampsia Prevention: Adherence to Low‐Dose Aspirin Use in Routine Obstetric Practice
The Journal of Clinical Hypertension, Volume 28, Issue 11, November 2026.
-
Blood Pressure Variability in Neurodegenerative Disease: Evidence From a Large‐Scale Remote Patient Monitoring Program
The Journal of Clinical Hypertension, Volume 28, Issue 11, November 2026.
-
New Insights Into Chronotherapy in Nondipper Hypertensive Patients
The Journal of Clinical Hypertension, Volume 28, Issue 11, November 2026.
-
Prevalence and One‐Year Incidence of Patient‐Healthcare Professional Discussions About Sexual Health in Hypertensive Adults in France: A Cohort Study
The Journal of Clinical Hypertension, Volume 28, Issue 11, November 2026.
-
Home Blood Pressure‐Guided Lifestyle Intervention for Elevated Blood Pressure Detected at Workplace Health Checkups: A Randomized Pilot Trial
The Journal of Clinical Hypertension, Volume 28, Issue 11, November 2026.
-
Continuous Associations and Predictive Performance of Electrocardiographic Voltage‐ and Product‐Based Indices for Incident Hypertension: A Prospective Cohort Study
The Journal of Clinical Hypertension, Volume 28, Issue 11, November 2026.
-
Comparison of Serum Uric Acid and Serum Uric Acid‐to‐Creatinine Ratio as Indicators of Metabolic Syndrome: A Cross‐Sectional Study in China
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
-
Sleeve Gastrectomy With Jejunojejunal Bypass Versus Sleeve Gastrectomy: 12‐Month Outcomes From a Propensity Score–Matched Analysis
Clinical Obesity, Volume 16, Issue 6, December 2026.
-
Metformin and Severe Post‐COVID‐19 Outcomes Among Individuals With Diabetes Mellitus
ABSTRACT Aims We evaluated the relationship between metformin, one of the most commonly prescribed medications for individuals with diabetes, and COVID‐19 sequelae. Materials and Methods We evaluated a retrospective cohort of...
-
Differences in the Glucose Management Indicator Between Continuous Glucose Monitoring Systems
ABSTRACT Aim The glucose management indicator (GMI) estimates HbA1c from continuous glucose monitoring (CGM)‐derived mean glucose. We assessed whether this relationship differs between contemporary CGM systems. Materials and Methods In...
-
Correction to “Letter to the Editor: The Association Between Glycemic Variability and the Risk of Diabetic Retinopathy Progression: A Community‐Based Retrospective Cohort Study”
Journal of Diabetes, Volume 18, Issue 11, November 2026.